INVERNESS COUNSEL LLC /NY/

13F Portfolio Filings

Most recent 13F
Q3 2022
Location
New York, NY
CIK
0000866361
Alternate names
INVERNESS COUNSEL INC /NY/
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q3 2022 187 1,798,417 ROP, CSL, DOV, MSFT 13F-HR 10/26/2022 000086636122000005
Q2 2022 170 1,782,232 ROP, CSL, DOV, MSFT 13F-HR 7/19/2022 000086636122000004
Q1 2022 191 2,232,634 ROP, DOV, CSL, MSFT 13F-HR 5/5/2022 000086636122000003
Q4 2021 191 2,712,653 ROP, DOV, MSFT, CSL 13F-HR 2/7/2022 000086636122000002
Q3 2021 179 2,721,985 ROP, DOV, AMZN, MSFT 13F-HR 11/2/2021 000086636121000005
Q2 2021 176 2,743,958 ROP, DOV, MSFT, CSL 13F-HR 8/10/2021 000086636121000004
Q1 2021 153 2,420,313 ROP, DOV, CSL, MSFT 13F-HR 5/4/2021 000086636121000003
Q4 2020 146 2,447,615 ROP, DOV, CSL, AMZN 13F-HR 1/27/2021 000086636121000002
Q3 2020 135 2,237,472 ROP, DOV, ADBE, AMZN 13F-HR 11/3/2020 000086636120000004
Q2 2020 125 2,008,712 ROP, DOV, CSL, MSFT 13F-HR 8/10/2020 000086636120000003
Q1 2020 117 1,593,318 ROP, DOV, CSL, MSFT 13F-HR 5/5/2020 000086636120000002
Q4 2019 129 2,116,909 ROP, DOV, CSL, MSFT 13F-HR 2/5/2020 000086636120000001
Q3 2019 118 1,932,851 ROP, CSL, MSFT, DOV 13F-HR 11/12/2019 000086636119000005
Q2 2019 117 1,957,464 ROP, CSL, DOV, MSFT 13F-HR 8/7/2019 000086636119000003
Q1 2019 117 1,835,532 ROP, CSL, DOV, MSFT 13F-HR 5/9/2019 000086636119000002
Q4 2018 117 1,493,213 ROP, CSL, MSFT, DOV 13F-HR 1/29/2019 000086636119000001
Q3 2018 132 1,900,043 ROP, CSL, MSFT, DOV 13F-HR 10/30/2018 000086636118000005
Q2 2018 133 1,758,761 ROP, CSL, MSFT, DOV 13F-HR 8/2/2018 000086636118000004
Q1 2018 146 1,661,854 ROP, CSL, DOV, MSFT 13F-HR 5/2/2018 000086636118000003
Q4 2017 100 1,593,544 ROP, CSL, DOV, MSFT 13F-HR 2/2/2018 000086636118000001
Q3 2017 99 1,415,926 ROP, CSL, DOV, MSFT 13F-HR 10/17/2017 000086636117000005
Q2 2017 93 1,440,398 ROP, DOV, CSL, MSFT 13F-HR 7/26/2017 000086636117000004
Q1 2017 95 1,435,870 ROP, DOV, CSL, ADBE 13F-HR 4/13/2017 000086636117000003
Q4 2016 93 1,321,544 ROP, CSL, DOV, MSFT 13F-HR 2/2/2017 000086636117000001
Q3 2016 90 1,271,170 ROP, CSL, DOV, META 13F-HR 11/7/2016 000086636116000009
Q2 2016 96 1,286,903 ROP, CSL, DOV, GE 13F-HR 8/4/2016 000086636116000008
Q1 2016 95 1,289,102 ROP, CSL, DOV, META 13F-HR 5/11/2016 000086636116000007
Q4 2015 106 1,320,992 ROP, CSL, DOV, META 13F-HR 2/4/2016 000086636116000006
Q3 2015 112 1,182,057 ROP, CSL, DOV, DIS 13F-HR 10/22/2015 000086636115000005
Q2 2015 112 1,378,844 ROP, CSL, DOV, MYL 13F-HR 7/16/2015 000086636115000004
Q1 2015 117 1,358,327 ROP, CSL, DOV, CAVM 13F-HR 4/14/2015 000086636115000002
Q4 2014 121 1,301,902 ROP, CSL, DOV, CAVM 13F-HR 1/20/2015 000086636115000001
Q3 2014 123 1,248,430 ROP, CSL, DOV, GILD 13F-HR 10/15/2014 000086636114000006
Q2 2014 125 1,280,973 ROP, CSL, DOV, ADBE 13F-HR 7/17/2014 000086636114000004
Q1 2014 117 1,258,121 ROP, CSL, DOV, GOOGL 13F-HR 4/15/2014 000086636114000002
Q4 2013 123 1,258,018 ROP, DOV, CSL, GILD 13F-HR 1/17/2014 000086636114000001